Literature DB >> 11466311

N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.

V A Lawson1, S A Priola, K Wehrly, B Chesebro.   

Abstract

Transmissible spongiform encephalopathy diseases are characterized by conversion of the normal protease-sensitive host prion protein, PrP-sen, to an abnormal protease-resistant form, PrP-res. In the current study, deletions were introduced into the flexible tail of PrP-sen (23) to determine if this region was required for formation of PrP-res in a cell-free assay. PrP-res formation was significantly reduced by deletion of residues 34-94 relative to full-length hamster PrP. Deletion of another nineteen amino acids to residue 113 further reduced the amount of PrP-res formed. Furthermore, the presence of additional proteinase K cleavage sites indicated that deletion to residue 113 generated a protease-resistant product with an altered conformation. Conversion of PrP deletion mutants was also affected by post-translational modifications to PrP-sen. Conversion of unglycosylated PrP-sen appeared to alter both the amount and the conformation of protease-resistant PrP-res produced from N-terminally truncated PrP-sen. The N-terminal region also affected the ability of hamster PrP to block mouse PrP-res formation in scrapie-infected mouse neuroblastoma cells. Thus, regions within the flexible N-terminal tail of PrP influenced interactions required for both generating and disrupting PrP-res formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466311     DOI: 10.1074/jbc.M103799200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Interactions between the conserved hydrophobic region of the prion protein and dodecylphosphocholine micelles.

Authors:  Simon Sauvé; Daniel Buijs; Geneviève Gingras; Yves Aubin
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

2.  Influence of the N-terminal domain on the aggregation properties of the prion protein.

Authors:  Kristen N Frankenfield; Evan T Powers; Jeffery W Kelly
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

3.  Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.

Authors:  Roger A Moore; Christian Herzog; John Errett; David A Kocisko; Kevin M Arnold; Stanley F Hayes; Suzette A Priola
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

4.  Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease.

Authors:  Silvio Notari; Rosaria Strammiello; Sabina Capellari; Armin Giese; Maura Cescatti; Jacques Grassi; Bernardino Ghetti; Jan P M Langeveld; Wen-Quan Zou; Pierluigi Gambetti; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

5.  MEK1 transduces the prion protein N2 fragment antioxidant effects.

Authors:  C L Haigh; A R McGlade; S J Collins
Journal:  Cell Mol Life Sci       Date:  2014-11-13       Impact factor: 9.261

6.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

7.  Identifying key components of the PrPC-PrPSc replicative interface.

Authors:  Gil C Abalos; Justin T Cruite; Anne Bellon; Saskia Hemmers; Junya Akagi; James A Mastrianni; R Anthony Williamson; Laura Solforosi
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

8.  The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Authors:  Valeriy G Ostapchenko; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

9.  Species and strain glycosylation patterns of PrPSc.

Authors:  Konstantinos Xanthopoulos; Magdalini Polymenidou; Sue J Bellworthy; Sylvie L Benestad; Theodoros Sklaviadis
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

10.  Identification of an intracellular site of prion conversion.

Authors:  Zrinka Marijanovic; Anna Caputo; Vincenza Campana; Chiara Zurzolo
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.